Category: New products
-
Immune Cell Chips to Launch into Space for Microgravity Tests
Chip devices with human immune system and stem cells are among the cargo set for launch today to the International Space Station.
-
Trial Results Show Gene Transfers Reverse Sickle Cell Disease
Results from the first 2 participants in a clinical trial show transferring healthy genes to patients with sickle cell disease reverses symptoms of the disease that continues for up to 1 year.
-
Electrode in Brain Blood Vessel Shown to Stimulate Body Muscles
Electrodes sent into a blood vessel in the brain with a catheter and stent are shown in tests with sheep to stimulate muscles in the animals’ faces and limbs.
-
Recap – Editas Medicine Advances Crispr Therapy
Editas Medicine received the go-ahead to conduct a clinical trial using the genome editing technique Crispr.
-
Trials OK’d for Inherited Eye Disease Therapy with Crispr
The company developing a treatment for a rare inherited eye disease using the genome editing technique Crispr received authorization from the Food and Drug Administration to begin clinical trials.
-
Nanotech Polymers Deliver More Effective Arthritis Therapy
A chemical engineering lab developed a process to help proteins combined with nanoscale polymers penetrate the cartilage in lab rodents and boost treatment for damage caused by osteoarthritis.
-
Prosthetic Joint Provides More Natural Wrist Movements
An academic-industry engineering team in Sweden developed and tested a prosthetic wrist joint that provides more natural movement and control than most current devices.
-
Personalized Computer Models Developed for Heart Disease
Researchers in the U.K. are developing computer models of heart functions that enable physicians to simulate recommended treatments for individual patients to gauge and optimize their outcomes.
-
Vital Signs Electronic Tag Designed to Aid First Responders
A simple electronic monitoring device that adheres to the chest aims to provide basic vital signs data to first responders and emergency medical staff in mass casualty situations.
-
Company Formed to Advance Sickle Cell Gene Therapy
A Swiss medical technologies company and Cincinnati Children’s hospital in Ohio are starting a new enterprise to commercialize research on gene therapies for inherited blood disorders.